Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease
Clinical trial NCT03522129 · COMPLETED
Trial details
- NCT number
- NCT03522129
- Sponsor
- Cognition Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-30
- Primary completion
- 2019-02-06
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.